DRUG: Esflurbiprofen and mentha oil Help Entry D10746            Mixture   Drug                                    Name Esflurbiprofen and mentha oil; Loqoa (TN) Component Esflurbiprofen [DR:D10254], Mentha oil [DR:D06461] Class Metabolizing enzyme substrate  DG01642  CYP2C9 substrate Remark Therapeutic category:  2649 Product:  D10746<JP> Efficacy Analgesic, Anti-inflammatory Comment Esflurbiprofen is metabolized by CYP2C9. Metabolism Enzyme: CYP2C9 [HSA:1559] Interaction DDI search Brite Therapeutic category of drugs in Japan [BR:br08301]  2  Agents affecting individual organs   26  Epidermides    264  Analgesics, anti-itchings, astringents, anti-inflammatory agents     2649  Others      D10746  Esflurbiprofen and mentha oil Drug groups [BR:br08330]  Metabolizing enzyme substrate   DG01642  CYP2C9 substrate    D10746  Esflurbiprofen and mentha oil New drug approvals in Japan [br08318.html]  Drugs with new active ingredients   D10746 Drug metabolizing enzymes and transporters [br08309.html]  Drug metabolizing enzymes   D10746 BRITE hierarchy Other DBs PubChem:  254741707 LinkDB All DBs » Japanese version   » Back

DBGET integrated database retrieval system